A Review of Precice Intramedullary Limb Lengthening (IMLL) System for Limb Lengthening Procedures in Children.

December 16, 2025 updated by: NuVasive

A Retrospective Review of Clinical and Radiographic Outcomes Following the Use of the Precice Intramedullary Limb Lengthening (IMLL) System in Pediatric Limb Lengthening Procedures

This study will look at how safe and effective limb lengthening surgeries are for the femur and tibia in children 12 years old and younger. We will examine any complications from the surgery, the results of X-rays, and feedback from patients. The study will involve the Precice Intramedullary Limb Lengthening (IMLL) System and external fixator devices for limb lengthening.

Study Overview

Detailed Description

As a retrospective chart review, all patients involved in this study will have undergone surgery for their limb length discrepancy according to the standard of care of the practitioner using either the Precice IMLL or an external fixator. Under this protocol, available patient outcomes, plain radiographs, and complications will be obtained from the existing medical records of all eligible index surgeries. An index surgery is defined as the first limb lengthening surgery performed by a study investigator on the index bone with either the Precice IMLL or an external fixator. Each patient may have up to 4 eligible index surgeries (right and left femur, right and left tibia) and be included in both the Precice IMLL and external fixator groups.

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • West Palm Beach, Florida, United States, 33407
        • Paley Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Pediatric (12 years and under) population

Description

Inclusion Criteria:

  • All potential index surgeries must meet the inclusion criteria below in order to be considered for enrollment:

    1. Patient was 12 years of age or younger at the time of the index surgery.
    2. Diagnosis of femoral or tibial limb length discrepancy greater than or equal to 2.0 cm.
    3. Limb length discrepancy secondary to congenital or acquired etiologies.
    4. Patients received limb lengthening treatment of the femur or tibia with the Precice IMLL System or an external fixator limb lengthening device.
    5. Minimum medullary canal diameter ≥6 mm in the treated bone - Precice IMLL System treatment group only.
    6. Closed or nonfunctioning physeal growth plates in the treated bone - Precice IMLL System treatment group only.
    7. Minimum of 12 months of follow-up.
    8. Available medical and radiographic records preoperatively through consolidation.

Exclusion Criteria:

  • Index surgeries will be excluded from consideration for the study if they meet any of the following criteria:

    1. Patients with unresolved limb lengthening-related adjacent joint contractures (loss of range of motion), subluxation, or dislocation prior to the index surgical procedure.
    2. Patients with uncorrected coronal or sagittal plane angular malalignment following the index surgical procedure.
    3. Patients with unresolved complications related to previous limb lengthening on the index or different limbs, including unhealed pin sites and/or residual bone infection (from external fixator devices) on the index limb.
    4. Patients with femoral head osteonecrosis from a previous implantation of a femoral nail prior to the index surgical procedure.
    5. Patients with a previous implantation of a femoral or tibial nail across an open physeal growth plate prior to the index surgical procedure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Precice IMLL System
Patients 12 years of age or younger received Precice IMLL for correction of limb length discrepancy.
The Precice IMLL System is composed of the Precice nail, screws, and uses an external remote controller (ERC) for rod distraction. The Precice IMLL System is designed to fit the anatomy of long bones and is intended to be placed internally in an intramedullary manner. It achieves limb correction through gradual lengthening or compression and providing intramedullary fixation for fractures of long bones.
External Fixator
Patients 12 years of age or younger received an external fixator for correction of limb length discrepancy.
External fixator devices consist of an external frame (ring, half-ring, monolateral, and rail); bone fixation is accomplished by the transcutaneous bone fixations implants (pins, wires, cables, screws), and the lengthening is accomplished by the vertical components (struts). Generally, femoral lengthening devices are monolateral and tibial lengthening devices have ring or half-ring frames. The external fixators are made of a variety of materials, including stainless steel, titanium, carbon fiber, and aluminum.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone (femur or tibia) lengthening
Time Frame: At least 1 yr post-op
Achievement of targeted limb length
At least 1 yr post-op
Osteotomy Healing
Time Frame: At least 1 yr post-op

Assessment of osteotomy healing using the following descriptors:

  • Premature healing: Defined as osteotomy healing before the target length is achieved.
  • Healed (consolidated): Defined as the presence of full corticalization (ossified) of regenerate bone of three of four cortices seen on AP and lateral radiographs.
  • Delayed union (consolidation): Defined as bone union taking greater than 6 months but with progressive improvement on radiographs and the osteotomy eventually healed.
  • Partial union (consolidation): Defined as incomplete bone healing, i.e., radiographic healing at only 1 or 2 cortices on AP and lateral views.
  • Nonunion (pseudarthrosis): Defined as lack of complete healing within 6 months of the end of the lengthening period.
At least 1 yr post-op
Frequency of device related complications
Time Frame: Post-op through at least 1 year post-op
Review of investigator-reported device-related complications
Post-op through at least 1 year post-op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Kyle Malone, Globus Medical

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 13, 2025

Primary Completion (Estimated)

July 30, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

November 7, 2024

First Submitted That Met QC Criteria

December 2, 2024

First Posted (Actual)

December 3, 2024

Study Record Updates

Last Update Posted (Actual)

December 22, 2025

Last Update Submitted That Met QC Criteria

December 16, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Limb Length Discrepancy

Clinical Trials on Intramedullary Limb Lengthening Device

Subscribe